Welcome to Pharma Nord Health News

- Dietary Supplements Based on Scientific Research.

Dear [NewsletterUserName]

Thank you for signing up for Pharma Nord Health News.

At Pharma Nord we greatly appreciate you wanting to learn more about our products and research.

Pharma Nord actively participates in international research and more than 300 scientific articles in which Pharma Nord's products have been tested have been released to date.

In this regard, Pharma Nord is among the leading companies on a global scale.

If, as a consumer, you want to invest in health and prevention with vitamins, minerals etc, then it is paramount that the tablet or capsule you are considering taking or recommending, has the intended effect. This is why it is important to choose products with documented effectiveness.

New research in coenzyme Q10 and selenium

In 2012 a large scale Swedish study was published in an international cardiovascular journal. Kisel-10 as the study is named showed the results of four years intake of Pharma Nords selenium and CoQ10 preparations in 444 seniors between 70 and 88 years of age.

This double blinded and placebo controlled study showed that the group who received CoQ10 and selenium was doing remarkably better than the group who received placebo. The preventive effect was visible in a series of medical conditions as well as in quality of life markers.

Likewise, in 2014 the Q-Symbio study showed a clear difference between patients who received Pharma Nord's CoQ10 preparation and patients who received placebo. The study was a multi center study conducted in thirteen hospitals in nine different countries and is one of the largest studies ever conducted on coenzyme Q10. The study was published in JACC: , one of the most renowned cardiovascular journals in the world.

In 2018, researcher Stefano Giannubilo published a study on age-related infertility in women between ages of 31 and 46. These women received 100mg of CoQ10 twice daily. The result has led researchers to the conclusion that oral supplementation with CoQ10 is suitable for women over the age of 35 years experiencing age-related infertility.

In 2019, Professor Professors Lopez-Lluch and colleagues in Spain conducted a study that showed superior absorption of Pharma Nord's CoQ10 preparation with ubiquinone and that the entire manufacturing process including the selection of oils and treatment of the CoQ10 raw material is more important for the absorption of different CoQ10 than the form (ubiquinone or ubiquinol ) CoQ10 comes in.

Legislation does not allow Pharma Nord to write about the specific findings of these studies. However it is possible to find more information about this subject via Google.

Read more about the studies here

Produced in Denmark

Pharma Nord is a 100 % Danish owned company with production facilities located in Denmark.

The factory is approved for medicine production therefore all products are processed following the same principles as if they were pharmaceutical drugs. This means extensive laboratory control of both raw materials and ready-made tablets and capsules. When the products leave the factory, the consumers can rest assured that the contents are active and pure, even on best before date.

See all products here

Focus on hygiene

All of Pharma Nord's tablets and capsules are produced in blister packaging which simultaneously ensures optimal hygiene and increase the product's quality and effect from the first pill to the last.

At the same time that makes it easy and practical for you to bring the vitamins in your bag or when you travel.

See our video about quality and why blister packaging is a better alternative to pill glasses.